24:28

Key Insights: A European Perspective on MPN & MDS

HMP Education

23:32

Genetic basis of MDS

HMP Education

25:13

Advances in understanding of MDS microenvironment

HMP Education

20:17

Role of immune system in MDS pathogenesis

HMP Education

23:06

New mouse models of MPN

HMP Education

20:29

Mechanisms of bone marrow fibrosis in Myelofibrosis

HMP Education

20:46

Biology and therapy of advanced systemic mastocytosis

HMP Education

21:29

Topical challenges in the management of ET

HMP Education

19:04

My view on current and future use of JAK inhibitors for ET, PV, and MF

HMP Education

23:32

Hypocellular MDS vs. aplastic anemia - Diagnosis and therapy

HMP Education

24:04

My approach to MDS management

HMP Education

21:10

Iron chelation therapy for MDS

HMP Education

23:37

Optimal use of lenalidomide as therapy for MDS

HMP Education

19:02

Experimental therapeutics in MDS – New opportunities

HMP Education

21:02

MF marrow morphology: Key takeaways from WHO 2016 diagnostic update

HMP Education

20:30

My approach to MF management

HMP Education

23:08

Clonal evolution of MPN to accelerated or blastic phase: Therapeutic insights

HMP Education

21:24

Experimental therapeutics in MPN: Where is the field going?

HMP Education